What is Retatrutide + Cagrilintide?

Retatrutide + Cagrilintide is a two-component co-lyophilized research blend offered as retatrutide 12.5 mg plus cagrilintide 2.5 mg, or retatrutide 25 mg plus cagrilintide 5 mg, per vial. The fixed-ratio formulation is intended for controlled analytical and laboratory studies; research on the individual components does not establish the performance, stability, or synergy of the combined product. For laboratory research use only. Sold only as a kit. For laboratory research only. Not for human or veterinary use.